If you wish to download the documents, please click on the links below:
Current EAMBES Governance and the past Executives of EAMBES.
The urgent need for biomedical engineers in the UK National Health Executive (NHS), the world’s largest healthcare system was highlighted by a new report entitled: Biomedical Engineering: Advancing UK healthcare. The report was published by the Institution of Mechanical Engineers UK on the 25 July 2014.
[Read the rest of this article...]
IMI 2 will hold an Open Info Day on its IMI 2-Call 1 in Brussels, Belgium on Tuesday 30 September 2014. In a similar vein to the Webinars held in July, the day will encompass an overview of IMI 2’s funding and intellectual property (IP) rules, funding advice so as to facilitate ease of applying under IMI 2, and workshops and presentations of the IMI 2-Call 1 Call topics by the project coordinator. Additionally, there will be plenty of networking opportunities and IMI staff will be on hand to answer questions relating to the new Call topics and the IMI 2 application procedures. It is important to note that additional information about the IMI 2-Call 1 will be communicated after approval by the IMI Governing Board (July/August 2014).
The Innovative Medicines Imitative 2 (IMI) has announced that it will hold a total of three webinars from the 11-15 July 2014 so as to better acquaint those wishing to apply for the IMI 2–Call 1 for proposals with the application process and the subject matters of the recently announce initial calls . This information was published in the IMI newsletter on the 30 June.
EAMBES have responded to the mHealth consultation which was launched by the European Commission on the 10 April 2014 and which could serve to promote the value Biomedical Engineering (BME).
The European Research Council (ERC) Work Programme for 2015 has been published on 23 July 2014. The ERC which is funded under Horizon 2020 has the unique idea of not having any particular topics as set criteria for funding and instead relies solely on the “excellence in science” principle to provide long-term funding for high-risk/ground breaking scientific pursuits.
On the 15 July 2014 Mr. Jean-Claude Juncker was elected as the President of the European Commission (EC) for the next legislative term. Mr. Juncker was elected following a 47-minute speech before a secret ballot, with 422 votes in favour (376 needed), 250 votes against, 47 abstentions and 10 void ballots.
On the 30 June 2014, the new Italian Presidency published a document setting out the Council’s work programme as established by the future trio of Presidencies (Italy, Latvia and Luxembourg), covering the period July 2014 to December 2015.
Following the publication on 21 March 2014 of the Regulation 282/2014 of the European Parliament and of the Council on the “Establishment of a third Programme for the Union's action in the field of health (2014-2020) “, on 11 April 2014 the European Commission, Directorate General for Health and Consumers (DG SANCO) hosted an the Information Day on the 3rd European Health Programme.
On the 20 June 2014, the European Council’s Employment and Social Policy Council (EPSCO) discussed the status of the Medical Devices Regulation.
The EU-funded project SOCIENTIZE (Society as e-Infrastructure through technology, innovation and creativity) is serving to highlight the role played by mHealth in the effective delivery of personalised patient treatment.